温控射频消融用于房颤肺静脉隔离的首次人体研究
本研究评估一种新型温控灌注射频导管(钻石嵌入头端和6个表面热电偶)用于肺静脉隔离的性能。猪模型显示51/55处病变透壁(92.7%);35例患者均成功隔离肺静脉,无焦痂或血栓。与35例力感知导管对照相比,研究组射频时间更短(26.3±5.2 min vs 89.2±27.2 min,p<0.001)、透视时间更短(11.2±8.5 min vs 19.5±6.8 min,p<0.001)、急性休眠肺静脉传导更低(0/35 vs 5/35,p=0.024)。
要点
- 温控灌注射频导管可快速、有效地实现肺静脉隔离
- 研究组射频和透视时间显著短于力感知导管对照组
- 3个月时84.8%的肺静脉对保持持久隔离
核心结论
- 首次人体研究显示温控灌注射频消融可产生快速、高效且持久的肺静脉隔离。
研究设计与样本
- 临床前猪模型6只行温度控制模式(60°C/50 W)心房消融至电图振幅降低约80%。
- 单中心临床可行性研究纳入35例患者为研究组,另35例使用标准力感知导管为对照组。
- 研究组计划3个月后无论症状如何均行肺静脉再标测。
主要发现
- 猪病变组织学显示55处病变中51处透壁(92.7%)。
- 患者中所有肺静脉均成功隔离,未观察到焦痂或血栓形成。
- 研究组平均射频时间26.3±5.2 min,对照组89.2±27.2 min(p<0.001)。
- 研究组平均透视时间11.2±8.5 min,对照组19.5±6.8 min(p<0.001)。
- 急性休眠肺静脉传导研究组0/35,对照组5/35(p=0.024)。
关键数值与推荐
- 3个月时23例患者接受再标测,46对肺静脉中39对(84.8%)保持持久隔离,涉及17例患者(73.9%)。
临床怎么用
- 该温控灌注射频导管可用于肺静脉隔离,可能缩短手术和透视时间。
局限性
- 临床部分为单中心小样本可行性研究,3个月再标测仅23例患者完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Saline irrigation improved the safety of radiofrequency (RF) ablation, but the thermal feedback for energy titration is absent. OBJECTIVES: To allow temperature-controlled irrigated ablation, a novel irrigated RF catheter was designed with a diamond-embedded tip (for rapid cooling) and 6 surface thermocouples to reflect tissue temperature. High-resolution electrograms (EGMs) from the split-tip electrode allowed rapid lesion assessment. The authors evaluated the preclinical and clinical performance of this catheter for pulmonary vein (PV) isolation. METHODS: Using the DiamondTemp (DT) catheter, pigs (n = 6) underwent discrete atrial ablation in a temperature control mode (60°C/50 W) until there was ∼80% EGM amplitude reduction. In a single-center clinical feasibility study, 35 patients underwent PV isolation with the DT catheter (study group); patients were planned for PV remapping after 3 months, regardless of symptomatology. A control group included 35 patients who underwent PV isolation with a standard force-sensing catheter. RESULTS: Porcine lesion histology revealed transmurality in 51 of 55 lesions (92.7%). In patients, all PVs were successfully isolated; no char or thrombus formation was observed. Compared with the control group, the study cohort had shorter mean RF application duration (26.3 ± 5.2 min vs. 89.2 ± 27.2 min; p < 0.001), shorter mean fluoroscopic time (11.2 ± 8.5 min vs. 19.5 ± 6.8 min; p < 0.001), and lower acute dormant PV reconduction (0 of 35 vs. 5 of 35; p = 0.024). At 3 months, 23 patients underwent remapping: 39 of 46 PV pairs (84.8%) remained durably isolated in 17 of these patients (73.9%). CONCLUSIONS: This first-in-human series demonstrated that temperature-controlled irrigated ablation produced rapid, efficient, and durable PV isolation. (ACT DiamondTemp Temperature-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation [TRAC-AF]; NCT02821351).
引用
- Iwasawa J, Koruth JS, Petru J, et al. Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017. PMID: 28750697. doi:10.1016/j.jacc.2017.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。